NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

We welcome the #NHSWorkforcePlan & the emphasis it places on; specialty training in cancer, investing in CNS & embracing innovations in tech. But there’s more to do if we’re to truly address the workforce crisis for those with #braintumours: https://t.co/hFqKjPiSNn

— The Brain Tumour Charity (@BrainTumourOrg) July 3, 2023

Reforming the ways of working in the NHS is a key part of delivering the Workforce Plan. It has outlined how they will work going forward so staff can spend more time with patients. This includes working closely as part of multidisciplinary teams and harnessing digital and technological innovations. Working in a more integrated and innovated way is very much welcome. This is something that the brain tumour community have previously faced challenges with. There is much innovation within diagnosis and potential treatment, including liquid biopsy and DCVax-L. Unfortunately, this has previously not been widely embraced in the field of brain tumours. We look forward to working with the NHS to roll out some of these innovations that will specifically support patients with brain tumours.